Bent U. Frandsen

Chief Executive Officer at ExpreS2ion

Bent Frandsen holds a MSc in Finance and Strategic Planning from Copenhagen Business School, Denmark.

He has more than 27 years of professional experience in management, finance, and business development positions in multinational companies, including more than 24 years life science experience at public listed companies: Lundbeck, ALK-Abelló, Coloplast, and private companies: NsGene, CMC Biologics, and Amphidex.

He is experienced in licensing, services, M&A, and new cash deals in excess of €200 million, and has furthermore been in charge of successfully closing numerous collaboration agreements pertaining to research and development of both new chemical entities and biologicals.

Bent Frandsen is employed since 2016 and was appointed CEO in 2019.

Location

Hørsholm, Denmark

Links

Previous companies


Org chart


Teams


Offices


ExpreS2ion

ExpreS2ion Biotechnologies is a biotech company within protein production in Drosophila Schneider-2 (S2) cells.


Headquarters

Hørsholm, Denmark

Employees

11-50

Links